- •Cost effectiveness of comprehensive CT scan for cancer detection after unprovoked VTE is assessed.
- •Comprehensive CT screening was more costly than limited screening alone.
- •CT screening was not more effective in improving quality of life or detecting occult cancers.
- •Implementing comprehensive CT screening after unprovoked VTE was not found to be cost effective.
Participants and setting
Main outcomes and measures
Conclusions and relevance
Abbreviations:VTE (venous thromboembolism), CT (comprehensive computed tomography)
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism?.Ann. Intern. Med. 2008; 149: 323-333
- Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults.Arch. Intern. Med. 2005; 165: 1782-1787
- Guidance for the prevention and treatment of cancer-associated venous thromboembolism.J. Thromb. Thrombolysis. 2016; 41: 81-91
- Screening for occult cancer in unprovoked venous thromboembolism.N. Engl. J. Med. 2015; 373: 697-704
- Economic and Fiscal Outlook.2016
- Ontario Case Costing Initiative.(Accessed Mar 2016)
- Accessed Jan 12, 2016) (
- Schedule of Benefits for Physician Services Under the Health Insurance Act.(Accessed Jan 12, 2016)
- Schedule of Benefits for Laboratory Services.(Accessed Dec 2015)
- Laboratory Information Handbook.(Accessed Mar 23, 2016)2002
- CIHI Survey: ED spending in Canada: a focus on the cost of patients waiting for access to an in-patient bed in Ontario.Healthc. Q. 2009; 12: 25-28
- The PSA test: frequently asked questions.(Accessed Mar 23, 2016)
- Bank of Canada Inflation Calculator.(Accessed Mar 9, 2016)
- EuroQol - a new facility for the measurement of health related quality of life.Health Policy. 1990; 16: 199-208
- A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials.PharmacoEconomics. 2014; 32: 1157-1170
- Bootstrapping: estimating confidence intervals for cost-effectiveness ratios.QJM. 1999; 92: 177-182
- Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE study cohort.Am. J. Med. 2013; 126: 832.e13-832.e21
- Population Table, CANSIM, Table 051-0001.(Accessed: December 27, 2016)
- Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer.Arch. Intern. Med. 2009 Dec 14; 169: 2078-2086